| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 08/08/2001 | EP1121425A1 Stabilized bioactive peptides and methods of identification, synthesis and use |
| 08/08/2001 | EP1121378A1 A process for the preparation of a thrombus imaging agent |
| 08/08/2001 | EP1121377A1 Chelator incorporated arg-gly-asp (rgd) mimetic synthetic disintegrins as imaging agents |
| 08/08/2001 | EP0841918B1 Thrombin inhibitors |
| 08/08/2001 | CN1307588A Compounds with growth hormone releasing properties |
| 08/08/2001 | CN1307585A Novel aspartyl dipeptide ester derivatives and sweeteners |
| 08/08/2001 | CN1069316C Substituted 5-ring heterocycles, their preparation and use |
| 08/07/2001 | US6271393 Process for producing N2-(1(S)-carboxy-3-phenylpropyl)-L-lysyl-L-proline |
| 08/07/2001 | US6271342 Sugar-modified cytostatics |
| 08/07/2001 | US6271235 HIV protease inhibitors |
| 08/07/2001 | US6270957 Non-Imuunosuppressive cyclosporins and their use in the prevention and treatment of HIV infection |
| 08/07/2001 | CA2092919C Epoxysuccinamic acid derivatives |
| 08/07/2001 | CA2025607C Hydrophilic derivatives, their application to diagnosis and to therapeutics, diagnostic or therapeutic kits and immunological reagents |
| 08/02/2001 | WO2001055329A2 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055176A2 Methods for inhibiting smooth muscle cell proliferation |
| 08/02/2001 | WO2001055175A2 Process for the preparation of acetyl-amidiniophenylalanyl-cyclohexylglycyl-pyridinioalaninamides |
| 08/02/2001 | WO2001055174A2 Universal procedure for refolding recombinant proteins |
| 08/02/2001 | WO2001055091A1 Solid-supported process for making n-substituted peptide mimetic compounds |
| 08/02/2001 | WO2001054690A1 Pharmaceutical compositions containing anti-beta 1 integrin compounds and uses |
| 08/02/2001 | WO2000067801A3 Prodrugs of chemotherapeutic agents with oxaalkanoic acids |
| 08/02/2001 | WO2000066175A3 Conjugates as therapies for cancer and prostate diseases |
| 08/02/2001 | CA2393954A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2366828A1 Preparation and use of polymers crosslinked with tyrosine-containing peptides |
| 08/01/2001 | EP1119528A2 Chemical constructs and their uses |
| 08/01/2001 | EP0877737B1 Novel n-(arylsulphonyl)amino acid derivatives having bradykinin receptor affinity |
| 08/01/2001 | EP0649434B1 Radioactively-labeled somatostatin-derived peptides for imaging and therapeutic uses |
| 08/01/2001 | CN1306541A Compound for unstable dipeptidyl peptidase IV inhibitors |
| 08/01/2001 | CN1306540A Prodrugs of dipeptidyl peptidase IV inhibitors |
| 08/01/2001 | CN1306539A Octahydro-6,10-dioxo-6h-pyridazino/1,2-a//1,2/diazepin-1-carboxylic acid derivatives, prepn. method and use for preparing therapeutically active compounds |
| 08/01/2001 | CN1306515A Combinations of protein farnesyltransferase and HMG COA reductase inhibitors and their use to treat cancer |
| 07/31/2001 | US6268207 Resolution of enantiomers from a mixture of (1r,2s)/(1s,2s)-1-amino-2-vinylcyclopropyl carboxylic acid methyl ester comprising the step of treating said mixture with an esterase to obtain the corresponding (1r,2s) enantiomer |
| 07/31/2001 | US6267973 Ectoin and ectoin derivatives as moisturizers in cosmetics |
| 07/31/2001 | US6267965 Vectors for insertion and expression of foreign genes for use as safe immunization vehicles to elicit immune response against poxvius-ctyomegalovirus and human cytomegalovirus |
| 07/26/2001 | WO2001053355A1 An in vivo screen using chemical inducers of dimerization |
| 07/26/2001 | WO2001053330A2 High purity lipopeptides, lipopeptide micelles, processes for preparing same and pharmaceutical compositions containing them |
| 07/26/2001 | WO2001053255A1 Gamma-secretase inhibitors |
| 07/26/2001 | WO2001053243A1 Novel arylpropionaldehyde derivatives and production and use of the same |
| 07/26/2001 | WO2001052880A1 Cyclic peptides as potent and selective melanocortin-4 receptor antagonists |
| 07/26/2001 | WO2001002601A3 Cell-based assay systems for examining hcv ns3 protease activity |
| 07/26/2001 | US20010009901 Antineoplastic peptides |
| 07/26/2001 | CA2743326A1 High purity lipopeptides, lipopeptide micelles and processes for preparing same |
| 07/26/2001 | CA2398010A1 An in vivo screen using chemical inducers of dimerization |
| 07/26/2001 | CA2397543A1 Gamma-secretase inhibitors |
| 07/26/2001 | CA2396307A1 Cyclic peptides as potent and selective melanocortin-4 receptor antagonists |
| 07/25/2001 | EP1117676A1 Propanolamine derivatives linked with bile acid used for treating disorders of the lipid metabolism |
| 07/25/2001 | EP1117660A1 Thrombin inhibitors |
| 07/25/2001 | EP0906333B1 Substrates and inhibitors of proteolytic enzymes |
| 07/25/2001 | EP0684944B1 Coupling product obtained from hystamine and an amino acid |
| 07/25/2001 | EP0649312B1 Anthracycline conjugates, their preparation and their use as antitumor agents |
| 07/25/2001 | CN1305492A Phrazinone protease inhibitors |
| 07/25/2001 | CN1305491A Crystalline forms of 1S-[1a(pha(2S, 3R), 9alpha]-6,10-dioxo-N-(2-ethoxy-5-oxo-tetrahydro-3-furanyl)-9-[[(1-isoquinolyl)carbonyl]-amino] actahydro-6H-piridazino [1,2-A][1,2] diazepin-1-carboxamide |
| 07/25/2001 | CN1305487A Benzo (b) thiepine-1, 1-dioxide derivatives, method for production thereof, medicaments containing these compounds and their use |
| 07/25/2001 | CN1305469A Benzothiepine-1, 1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use |
| 07/24/2001 | US6265572 Inhibit binding of integrin expressing cells to cell adhesion molecules of endothelium |
| 07/24/2001 | US6265382 Dipeptide inhibitors of protein farnesyltransferase |
| 07/24/2001 | US6265381 Morpholinourea and related derivatives of pentafluoroethyl peptides |
| 07/24/2001 | US6265380 Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease |
| 07/24/2001 | US6265374 Peptide T and related peptides in the treatment of inflammation, including multiple sclerosis |
| 07/24/2001 | CA2230303C Polymorphs of the prodrug 6-n-(l-ala-l-ala)-trovafloxacin |
| 07/24/2001 | CA2191844C Acylated enol derivatives as prodrugs of elastase inhibitors |
| 07/24/2001 | CA2092652C Antiherpes peptide derivatives having a ureido n-terminus |
| 07/24/2001 | CA2065299C Direct radiolabeling of antibodies and other proteins with technetium or rhenium |
| 07/24/2001 | CA2027936C Cyclic anti-aggregatory peptides |
| 07/19/2001 | WO2001051524A1 Cyclodextrin dimers with spacers having peptide structures for encapsulation of pharmaceutically active substances with potential high side-effects |
| 07/19/2001 | WO2001051506A2 Oligomers of nonpeptide restricted mimetics of dipeptides or tripeptides and the use thereof in the synthesis of synthetic proteins and polypeptides |
| 07/19/2001 | WO2001051462A1 INHIBITORS OF THE ICE/Ced-3 FAMILY OF CYSTEINE PROTEASES |
| 07/19/2001 | WO2001002424A3 Peptide boronic acid inhibitors of hepatitis c virus protease |
| 07/19/2001 | US20010008933 Novel disulfides and thiol compounds |
| 07/19/2001 | CA2395975A1 Inhibitors of the ice/ced-3 family of cysteine proteases |
| 07/18/2001 | EP1116726A1 Ethylamine derivatives |
| 07/18/2001 | EP1115874A2 Alzheimer's disease secretase |
| 07/18/2001 | EP1115741A2 Stereoselective process for enalapril |
| 07/18/2001 | EP1115738A1 Synthesis of cyclic peptides |
| 07/18/2001 | EP1115414A2 Inhibition of erythrocyte sickling by n-l-alpha-aspartyl-l-phenylalanine 1-methyl ester |
| 07/18/2001 | EP1115390A1 Hydroxamate-containing cysteine and serine protease inhibitors |
| 07/18/2001 | EP1093458A4 Process for the preparation of resin-bound cyclic peptides |
| 07/18/2001 | EP0850221B1 Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists |
| 07/18/2001 | CN1304415A Preparation and purification of organic salt of aspartame |
| 07/18/2001 | CN1304414A Preparation of organic salt of aspartame |
| 07/18/2001 | CN1304406A Heterocyclic glycyl beta-alanine derivatives as vitronectin antagonists |
| 07/18/2001 | CN1304392A Process for producing carboxylic acid derivative and condensing agent comprising quaternary ammonium salt |
| 07/17/2001 | US6262277 Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 07/17/2001 | US6262264 Redox reversible imidazole osmium complex conjugates |
| 07/17/2001 | US6262089 Using these compounds to treat diseases associated with amyloidosis, such as alzheimer's disease, maturity onset diabetes mellitus, familial amyloid polyneuropathy, scrapie, and kreuzfeld-jacob disease. |
| 07/17/2001 | US6262080 3-(thio-substitutedamido)-lactams useful as inhibitors of matrix metalloproteinase |
| 07/17/2001 | US6262069 1-amino-7-isoquinoline derivatives as serine protease inhibitors |
| 07/17/2001 | US6262047 Selective factor Xa inhibitors |
| 07/17/2001 | US6262028 CONTAINING OXY-SUBSTITUTED AMIDINOBENZYL DERIVATIVES OF DIPEPTIDES FROM CYCLOHEXYLGLYCINE AND AZETIDINE-2-CARBOXYLIC ACID; ximelagatran |
| 07/17/2001 | US6262023 WD-40 derived peptides and uses thereof |
| 07/17/2001 | US6262017 Peptides for altering osteoblast adhesion |
| 07/17/2001 | US6261810 Enzymatic oxidative deamination process |
| 07/17/2001 | US6261794 Combining a sample with a n-terminal methionine peptide and a second peptide with a c-terminal detection moiety that is released by a second peptidase only if the n-terminal peptide has been cleaved by methionine aminopeptidase |
| 07/17/2001 | US6261774 Truncation selex method |
| 07/17/2001 | US6261569 Antigens; mixed with carriers; genetic engineering |
| 07/12/2001 | WO2001049691A1 CAMPTOTHECIN β-ALANINE ESTERS WITH TOPOISOMERASE I INIBHITION |
| 07/12/2001 | WO2001027096A9 Aminomethyl-(hetero)aryl derivatives and their use as tryptase inhibitors |
| 07/12/2001 | WO2001008677A8 Methods of inhibiting osteoclast activity |
| 07/12/2001 | WO2001000657A3 Novel indole peptidomimetics as thrombin receptor antagonists |
| 07/12/2001 | US20010007764 Oligopeptides |
| 07/11/2001 | EP1114828A1 N-alkylaspartyldipeptide ester derivatives and sweeteners |